관절 내 관절액 보충요법 시장 보고서(2026년)

Viscosupplementation is a process in which hyaluronic acid, a gel-like fluid, is injected directly into a joint. Synovial fluid, naturally present around joints, contains hyaluronic acid, which helps reduce friction during movement.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection viscosupplementation. Single-injection viscosupplementation involves a single shot of hyaluronic acid injected directly into the diarthrodial joints of a person's knees, aimed at restoring the rheological properties of the synovial fluid, thereby providing anti-inflammatory and analgesic effects. Hyaluronic acid, including both standard and stabilized forms, can be derived from avian and non-avian sources. These treatments are used to manage various osteoarthritides, including knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis, and are administered in settings such as hospitals, ambulatory surgical centers, and others.

Tariffs have impacted the viscosupplementation market by increasing the cost of imported hyaluronic acid and related injectable components, leading to higher production and treatment costs. This disruption particularly affects single, three, and five injection types and regions heavily reliant on imports, such as North America and Europe. Hospitals and ambulatory surgical centers face cost pressures, while local manufacturing initiatives may see growth. Overall, tariffs are driving manufacturers to explore domestic sourcing and cost-efficient innovations.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis, increasing geriatric population, advancements in joint care therapies, growing awareness of viscosupplementation, expanding orthopedic healthcare infrastructure.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to adoption of regenerative medicine, integration of digital health monitoring, development of novel hyaluronic acid formulations, expansion of ambulatory surgical centers, rising investments in outpatient orthopedic procedures. Major trends in the forecast period include minimally invasive joint therapies, regenerative medicine integration, personalized osteoarthritis treatment, injectable hyaluronic acid innovations, outpatient orthopedic procedures.

The growing prevalence of osteoarthritis is expected to drive the expansion of the viscosupplementation market in the coming years. Osteoarthritis, a degenerative joint disease and a common form of arthritis, occurs when the joints, particularly in the hips, knees, and hands, begin to deteriorate. Viscosupplementation treatments help alleviate pain and facilitate smooth bone movement by injecting hyaluronic acid directly into the joints, reducing pain and improving joint functionality. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based nonprofit global health research center, reported that by 2050, osteoarthritis of the knee is expected to increase by 75%, and osteoarthritis of the hand by 50%. Therefore, the rising prevalence of osteoarthritis is driving the growth of the viscosupplementation market.

Leading companies in the viscosupplementation market are focusing on developing innovative products, such as resorbable hyaluronic acid scaffolds, to improve joint lubrication, promote tissue regeneration, and offer long-lasting relief from osteoarthritis symptoms, thereby enhancing patient outcomes and broadening treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made from hyaluronic acid (HA), a naturally occurring polysaccharide in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a U.S.-based company specializing in orthopedics, launched Hyalofast, a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold for cartilage repair. Hyalofast provides a hyaluronic acid-based solution for joint preservation, potentially offering an alternative to more invasive surgical procedures.

In August 2025, Ono Pharmaceutical Co., Ltd., a Japan-based provider of pharmaceuticals and medical products, partnered with Seikagaku Corporation to co-develop and market Gel-One, a hyaluronic acid-based viscosupplement for osteoarthritis. Through this partnership, the companies aim to expand their presence in the Japanese viscosupplementation market by combining Seikagaku's product development and manufacturing expertise with Ono's marketing and distribution network. Seikagaku Corporation is a Japan-based developer and manufacturer of hyaluronic acid therapeutics, including injectable viscosupplements for joint health.

Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

North America was the largest region in the viscosupplementation market in 2025. The regions covered in the viscosupplementation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
• 2) By Source: Avian Origin; Non-Avian Origin
• 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
• 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
• 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
• 2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
• 3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
• Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Zimmer Biomet; Johnson & Johnson Services Inc.; Aptissen S.A.; Smith & Nephew Plc.; Flexion Therapeutics Inc.; Regen Lab SA; OrthogenRx Inc.; Fidia Farmaceutici S.P.A; Ferring Pharmaceuticals; Laboratoires VIVACY; Allergan; Hyalgan; Synvisc; Euflexxa; Sanofi S.A.; Wellchem Pharmaceuticals Pte Ltd; Medtronic Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Viscosupplementation Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Viscosupplementation Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Viscosupplementation Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Viscosupplementation Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Minimally Invasive Joint Therapies
  • 4.2.2 Regenerative Medicine Integration
  • 4.2.3 Personalized Osteoarthritis Treatment
  • 4.2.4 Injectable Hyaluronic Acid Innovations
  • 4.2.5 Outpatient Orthopedic Procedures

5. Viscosupplementation Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Orthopedic Clinics
• 5.4 Rehabilitation Centers
• 5.5 Sports Medicine Centers

6. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viscosupplementation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Viscosupplementation Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Viscosupplementation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Viscosupplementation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viscosupplementation Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viscosupplementation Market Segmentation

• 9.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
• 9.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Avian Origin, Non-Avian Origin
• 9.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
• 9.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
• 9.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Surgical Centers, Other End-Users
• 9.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
• 9.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hyaluronic Acid-Based Products, Combination Products
• 9.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hyaluronic Acid-Based Products, Combination Products

10. Viscosupplementation Market Regional And Country Analysis

• 10.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viscosupplementation Market

• 11.1. Asia-Pacific Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viscosupplementation Market

• 12.1. China Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viscosupplementation Market

• 13.1. India Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viscosupplementation Market

• 14.1. Japan Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viscosupplementation Market

• 15.1. Australia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viscosupplementation Market

• 16.1. Indonesia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viscosupplementation Market

• 17.1. South Korea Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viscosupplementation Market

• 18.1. Taiwan Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viscosupplementation Market

• 19.1. South East Asia Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viscosupplementation Market

• 20.1. Western Europe Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viscosupplementation Market

• 21.1. UK Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viscosupplementation Market

• 22.1. Germany Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viscosupplementation Market

• 23.1. France Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viscosupplementation Market

• 24.1. Italy Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viscosupplementation Market

• 25.1. Spain Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viscosupplementation Market

• 26.1. Eastern Europe Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viscosupplementation Market

• 27.1. Russia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viscosupplementation Market

• 28.1. North America Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viscosupplementation Market

• 29.1. USA Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viscosupplementation Market

• 30.1. Canada Viscosupplementation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viscosupplementation Market

• 31.1. South America Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viscosupplementation Market

• 32.1. Brazil Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viscosupplementation Market

• 33.1. Middle East Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viscosupplementation Market

• 34.1. Africa Viscosupplementation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viscosupplementation Market Regulatory and Investment Landscape

36. Viscosupplementation Market Competitive Landscape And Company Profiles

• 36.1. Viscosupplementation Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Viscosupplementation Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Viscosupplementation Market Company Profiles
  • 36.3.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Viscosupplementation Market Other Major And Innovative Companies

• Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

38. Global Viscosupplementation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viscosupplementation Market

40. Viscosupplementation Market High Potential Countries, Segments and Strategies

• 40.1 Viscosupplementation Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Viscosupplementation Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Viscosupplementation Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer